Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection.

@article{Shuqun2006AntiviralTU,
  title={Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection.},
  author={Cheng Shuqun and Wu Mengchao and Chen Han and Shen Feng and Yang Jiahe and Cong Wenming and Yin Zhengfeng and Zhao Yuxiang and Wang Peijun},
  journal={Hepato-gastroenterology},
  year={2006},
  volume={53 68},
  pages={249-52}
}
BACKGROUND/AIMS To observe the recurrence and prognosis of patients with hepatocellular carcinoma (HCC) coexisting with chronic hepatitis B infection with active virus replication after receiving antivirus therapy using lamivudine and thymosin alpha1 postoperatively. METHODOLOGY From Jan. 2000 to Dec. 2002, 33 patients with HCC coexisting chronic… CONTINUE READING